CTLA4 and cancer: There are currently several ongoing investigations but the most promising results for cancer therapy have been obtained by targeting the Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and Programmed T cell death 1 (PD-1) receptors [34,35,36,37].